INS and Insulin resistance: In addition, in several studies Silibinin has been shown to be an insulin sensitizer and could effectively reduce glucose plasma concentrations in type 2 diabetes mellitus and NAFLD patients, reflected in an enhanced homeostasis model assessment of insulin-resistance values [26–28].